DM-CHOC-PEN

4-Demethyl-4-cholesteryloxycarbonylpenclome · DEKK-TEC, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for DM-CHOC-PEN, covering 2020-09-16 to 2022-11-08. Get the full timeline:

Most recent: Clinical Trial Update: DM-CHOC-PEN for Brain Tumors in AYA Subjects [Phase 2]